Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evolent Health (EVH)
NYSE:EVH
Holding EVH?
Track your performance easily
EVH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$10.82 - $35.00
Previous Close$11.1
Volume3.69M
Average Volume (3M)2.56M
Market Cap
$1.27B
Enterprise Value$1.81B
Total Cash (Recent Filing)$96.58M
Total Debt (Recent Filing)$635.21M
Price to Earnings (P/E)―
Beta0.48
Next Earnings
Feb 19, 2025EPS Estimate
$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding116,563,910
10 Day Avg. Volume2,876,598
30 Day Avg. Volume2,556,480
Standard Deviation0.19
R-Squared0.15
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)1.22
Price to Sales (P/S)0.53
Price to Cash Flow (P/CF)17.30
P/FCF Ratio26.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.73
Enterprise Value/Gross Profit3.92
Enterprise Value/Ebitda34.33
Forecast
1Y Price Target
$24.15Price Target Upside125.49% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
Evolent Health News
Bulls Say, Bears Say
Bulls Say
Earnings GrowthEvolent Health is believed to be capable of driving 20% or more in adjusted EBITDA growth moving forward.
New Business DevelopmentEvolent Health Inc. entered into six new agreements, including one PS oncology contract and five Tech & Services contracts, highlighting strong new business activity.
Revenue GrowthEstimated 2025 revenue for Performance Suite is $2.23B, representing a year-over-year growth of 23%.
Bears Say
Financial PerformanceManagement revised its 2024 adjusted EBITDA guidance to $160-$175M from $230-$245M following an unexpected $42M increase in Performance Suite medical claims expense.
Market ReactionShares of Evolent Health Inc. dropped more than 30% in aftermarket trading due to recent financial challenges.
Revenue And EarningsEvolent Health's revenue and adjusted EBITDA for 3Q24 fell short of estimates due to higher-than-expected costs in the Performance Suite business.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
EVH FAQ
What was Evolent Health’s price range in the past 12 months?
Evolent Health lowest stock price was $10.82 and its highest was $35.00 in the past 12 months.
What is Evolent Health’s market cap?
Currently, no data Available
When is Evolent Health’s upcoming earnings report date?
Evolent Health’s upcoming earnings report date is Feb 19, 2025 which is in 62 days.
How were Evolent Health’s earnings last quarter?
Evolent Health released its earnings results on Nov 07, 2024. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.31 by -$0.27.
Is Evolent Health overvalued?
According to Wall Street analysts Evolent Health’s price is currently Undervalued.
Does Evolent Health pay dividends?
Evolent Health does not currently pay dividends.
What is Evolent Health’s EPS estimate?
Evolent Health’s EPS estimate is $0.03.
How many shares outstanding does Evolent Health have?
Evolent Health has 116,563,910 shares outstanding.
What happened to Evolent Health’s price movement after its last earnings report?
Evolent Health reported an EPS of $0.04 in its last earnings report, missing expectations of $0.31. Following the earnings report the stock price went down -45.625%.
Which hedge fund is a major shareholder of Evolent Health?
Among the largest hedge funds holding Evolent Health’s share is RA Capital Management. It holds Evolent Health’s shares valued at 241M.
---
Evolent Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$24.15 (125.49% Upside)
$24.15 (125.49% Upside)
Blogger Sentiment
Bullish
EVH Sentiment 80%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 576.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days <0.1%
Last 30 Days ▲ 3.7%
Last 30 Days ▲ 3.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-6.77%
Trailing 12-Months
Asset Growth
-6.29%
Trailing 12-Months
Company Description
Evolent Health
Evolent Health, Inc. engages in the provision of health care delivery and payment services. Its solutions include population health management, health plan administration and third party administration, network performance management, risk adjustment, pharmacy benefit management, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services segment and True Health segment. The Services segment includes three types of services designed to help partners manage patient health; value-based care services, specialty care management services and comprehensive health plan administration services. The True Health segment, which operates a health plan in New Mexico, and provides reinsurance to NMHC, takes on certain insurance and underwriting costs in pricing its premiums. The company was founded by Frank J. Williams, Seth B. Blackley, and Tom Peterson in August 2011 and is headquartered in Arlington, VA.
---
EVH Company Deck
---
EVH Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted Evolent's strong market position and record business signings, but was overshadowed by significant challenges related to increased medical costs, earnings shortfall, and the need for additional rate negotiations. Despite long-term growth expectations, the immediate financial performance and operational hurdles present a cautious outlook.Read More>---
EVH Stock 12 Month Forecast
Average Price Target
$24.15
▲(125.49% Upside)
Technical Analysis
Best Analysts Covering EVH
1 Year
1 Year Success Rate
20/46 ratings generated profit
1 Year Average Return
+12.01%
reiterated a buy rating last month
Copying Richard Close's trades and holding each position for 1 Year would result in 43.48% of your transactions generating a profit, with an average return of +12.01% per trade.
---